SCHEMBL231244

SCHEMBL231244

OCC1CCC[N]C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4164859 1.00
SCHEMBL539152 0.84
SCHEMBL538966 0.84
SCHEMBL539058 0.84
SCHEMBL1032594 0.81
SCHEMBL9664093 0.75
SCHEMBL1489690 0.75
SCHEMBL4925273 0.75
SCHEMBL1547219 0.75
SCHEMBL322347 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 397 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110372657-B 7-O-acylamino substituted hesperetin derivative and preparation method and application thereof 安徽医科大学 2021-06-04 CN claimed
CN-110818648-B Pleuromutilin derivative with triazole side chain as well as preparation method and application thereof 华南农业大学 2021-03-16 CN claimed
US-20210069159-A1 Bach1 Inhibitors in Combination with Nrf2 Activators and Pharmaceutical Compositions Thereof VTV THERAPEUTICS LLC 2021-03-11 US claimed
US-10898475-B2 Bach1 inhibitors in combination with Nrf2 activators and pharmaceutical compositions thereof VTV THERAPEUTICS LLC (US) 2021-01-26 US claimed
CN-110818648-A Pleuromutilin derivative with triazole side chain as well as preparation method and application thereof 华南农业大学 2020-02-21 CN claimed
US-10155770-B2 Substituted pyrazolopyrimidines and method of use ABBVIE INC. (US) 2018-12-18 US claimed
EP-3286192-A1 SUBSTITUTED PYRAZOLOPYRIMIDINES AND METHOD OF USE AbbVie Deutschland GmbH & Co KG (DE) 2018-02-28 EP claimed
US-9828381-B2 Substituted pyrazolopyrimidines and method of use AbbVie Deutschland GmbH & Co. KG (DE) 2017-11-28 US claimed
WO-2017153789-A1 BENZO[B]THIOPHENE DERIVATIVES AND THEIR USE FOR THE INHIBITION OF FIBROBLAST GROWTH FACTOR RECEPTOR KINASES (FGFRS) FOR THE USE OF NEO- AND HYPERPLASIA THERAPIES VICHEM CHEMIE KUTATÓ KFT. (HU) 2017-09-14 WO claimed
WO-2016169995-A1 SUBSTITUTED PYRAZOLOPYRIMIDINES AND METHOD OF USE AbbVie Deutschland GmbH & Co. KG (DE) 2016-10-27 WO claimed
WO-2002080926-A1 PYRAZOLOPYRIMIDINES AS THERAPEUTIC AGENTS ABBOTT GMBH & CO. KG (DE) 2002-10-17 WO claimed
WO-2002076986-A1 PYRAZOLOPYRIMIDINES AS THERAPEUTIC AGENTS ABBOTT GMBH & CO. KG (DE) 2002-10-03 WO claimed
WO-2002057261-A2 DIAMINOTHIAZOLES AND THEIR USE AS INHIBITORS OF CYCLIN-DEPENDENT KINASE F. HOFFMANN-LA ROCHE AG (CH) 2002-07-25 WO claimed
EP-0490769-B1 Aminoalkylketone derivatives, process for their preparation and their therapeutical use LAFON LABOR (FR) 1995-04-19 EP claimed
EP-0536151-B1 ORTHOSUBSTITUTED BIPHENYL GUANIDINE DERIVATIVES AND ANTIDIABETIC OR HYPOGLYCAEMIC AGENTS CONTAINING THEM BOOTS CO PLC (GB) 1994-09-14 EP claimed
US-5302720-A Biphenyl-substituted guanidine derivatives useful as hypoglycaemic agents THE BOOTS COMPANY (GB) 1994-04-12 US claimed
EP-0536151-A1 ORTHOSUBSTITUTED BIPHENYL GUANIDINE DERIVATIVES AND ANTIDIABETIC OR HYPOGLYCAEMIC AGENTS CONTAINING THEM. BOOTS CO PLC (GB) 1993-04-14 EP claimed
EP-0490769-A1 Aminoalkylketone derivatives, process for their preparation and their therapeutical use LABORATOIRE L. LAFON (FR) 1992-06-17 EP claimed
US-5120746-A Inhibit gastric acid secretion TOYAMA CHEMICAL CO., LTD. (JP) 1992-06-09 US claimed
WO-1992000273-A1 ORTHOSUBSTITUTED BIPHENYL AMIDINE AND BIPHENYL GUANIDINE DERIVATIVES AND ANTIDIABETIC OR HYPOGLYCAEMIC AGENTS CONTAINING THEM THE BOOTS COMPANY PLC (GB) 1992-01-09 WO claimed